Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
GMP Manufacturing Suite | 25/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy